Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index
ChemMedChem · 2025-06-02 · 20 (11)
DOI: 10.1002/cmdc.202500166 ↗At a glance
Journal article in ChemMedChem, published online on 2025-05-04. Written by Lea Ueberham and 8 co-authors. Institution: Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität Leipzig, Deuts…. Major MEDLINE topics: Flurbiprofen, Celecoxib, Cyclooxygenase 1, Cyclooxygenase 2. Cited 7 times so far (Crossref); 83 references. The full text is freely available (open access, CC BY 4.0). Funded by: German Research Foundation, CRC-Transregio, European Union - NextGenerationEU and the Romanian Government.
Abstract (original language)
The cylcooxygenase isoforms COX‐1 and COX‐2 are involved in the production of prostaglandins in physiological and pathological processes. The overexpression of COX‐2 under inflammatory conditions, its role in cancer and neurodegenerative diseases necessitates the need to develop and improve nonsteroidal anti‐inflammatory drugs. These mainly unselective COX inhibitors, e.g. aspirin, are used to reduce the symptoms of inflammation. To reduce unwanted side effects connected with unselective inhibition, the development of novel COX‐2 selective inhibitors is a major goal. Herein, the synthesis, characterization and in vitro biological evaluation of eight flurbiprofen‐ and celecoxib‐based carborane analogs are described. Carboranes as hydrophobic surrogates are suitable substituents that can contribute to a selectivity increase toward COX‐2 due to size exclusion. The inhibitory efficacy for COX‐1 and COX‐2 of the four ortho ‐ and four nido ‐carborane derivatives has been tested. The nido compounds are much more potent than their closo ‐carborane analogs. The celecoxib‐based nido ‐carborane compound 10 shows an IC 50 (COX‐2) value in the sub‐μM range and slight selectivity for COX‐2. This is in contrast to its ortho ‐carborane counterpart 9 , which shows an inhibition preference for COX‐1. While none of these carborane derivatives outperforms their organic analogs, the flurbiprofen‐based nido ‐carborane derivatives 14a and 14b surpass the known carborane‐based flurbiprofen analogs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität Leipzig, Deutscher Platz 5, 04103, Leipzig, Germany.
- Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Bautzner Landstraße 400, 01328, Dresden, Germany.
- School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- Faculty of Chemistry and Chemical Engineering Department of Chemistry, Babeş-Bolyai University, Str. Arany Janos Nr. 11, RO-400028, Cluj-Napoca, Romania.
ORCID profiles: Lea Ueberham, Jonas Schädlich, Sebastian Braun, Christoph Selg, Markus Laube, Peter Lönnecke, Jens Pietzsch, Evamarie Hey-Hawkins
Funding
- German Research Foundation
- CRC-Transregio
- European Union - NextGenerationEU and the Romanian Government
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
Cite
APA
Ueberham, L., Schädlich, J., Schramke, K., Braun, S., Selg, C., Laube, M., Lönnecke, P., Pietzsch, J., & Hey-Hawkins, E. (2025). Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index. ChemMedChem, 20(11). https://doi.org/10.1002/cmdc.202500166
Vancouver
Ueberham L, Schädlich J, Schramke K, Braun S, Selg C, Laube M, et al. Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index. ChemMedChem. 2025;20(11). doi:10.1002/cmdc.202500166
BibTeX
@article{Ueberham2025,
author = {Ueberham, Lea and Schädlich, Jonas and Schramke, Kim and Braun, Sebastian and Selg, Christoph and Laube, Markus and Lönnecke, Peter and Pietzsch, Jens and Hey-Hawkins, Evamarie},
title = {Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index},
journal = {ChemMedChem},
year = {2025},
volume = {20},
number = {11},
doi = {10.1002/cmdc.202500166}
}
EUVIMED